Acoramidis, an oral therapy, is now approved to reduce cardiovascular-related deaths and hospitalizations in adults with hereditary or wild-type ATTR-CM.
A recent randomized clinical trial demonstrated that a nurse and social worker-led palliative telecare intervention improved quality of life, mental health, and disease-specific outcomes for patients with...
This COVID-19 roundup includes coverage on the latest estimated number of adults with long COVID, WHO’s updated terminology for pathogens that transmit through the air, how COVID-19 vaccination reduces the...
Researchers compared the rates of elective vs emergency surgery for patients living in primary care shortage areas who had one of three access-sensitive surgical conditions.
Researchers compared the effects of once-weekly semaglutide (2.4 mg) with a placebo during a 52-week period in patients with HFpEF and a BMI of 30 or higher.
Researchers investigated the association and the potential sex differences between hypertension and blood pressure in early adulthood (ages 30-40 years) with late-life brain health.
Researchers set out to determine the percentage of people in the United States with type 2 diabetes who meet the recommended criteria to use GLP-1 receptor agonists and SGLT-2 inhibitors as well as patients...
Among those with statin-intolerance, bempedoic acid, an inhibitor used to decrease elevated levels of low-density lipoprotein cholesterol, was also associated with a lower risk of major adverse...
Did you watch our Multidisciplinary Roundtable on the current challenges and opportunities in digital health innovation for managing patients with heart failure with reduced ejection fraction? Here are some...
Researchers sought to determine whether adults hospitalized for sepsis are at an increased risk of death or rehospitalization for cardiovascular events.
